Comparison of PROMIS® Computerized Adaptive Testing versus Fixed Short Forms in Juvenile Myositis.
Ruchi N PatelValeria G EsparzaJin-Shei LaiElizabeth L GrayBryce B ReeveRowland W ChangDavid CellaKaveh ArdalanPublished in: Arthritis care & research (2021)
PROMIS CAT appears to be feasible and correlated with FSF. CAT had less pronounced floor/ceiling effects, allowing detection of individual differences in less symptomatic patients. Modified stopping rules for CAT may decrease respondent burden. CAT can be considered for long-term follow-up of JM patients.